共 50 条
- [1] PHASE I TRIAL OF HYPOFRACTIONATED INTENSITY-MODULATED RADIOTHERAPY WITH TEMOZOLOMIDE CHEMOTHERAPY FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (04): : 1066 - 1074
- [4] Phase II Trial of Hypofractionated IMRT With Temozolomide for Patients With Newly Diagnosed Glioblastoma Multiforme [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : 655 - 660
- [6] Phase II trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma [J]. Journal of Neuro-Oncology, 2015, 122 : 135 - 143
- [8] Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme [J]. Journal of Neuro-Oncology, 2010, 98 : 93 - 99